{
    "medicine_id": "ce0b8d1ae4419fc4ab91c807532b34f6a0d75494",
    "platform_id": "DB13444",
    "metadata": {
        "name": "Telebrix 38 Oral 66 g 100ml Injection solution",
        "composition": "66 g 100ml Ioxitalamic acid",
        "clinical_particulars": {
            "therapeutic_indications": "Ioxitalamate in both of its available forms is indicated for exploration of the digestive tract by tomodensitometry or by regular gastroduodenal radiography Its use is restrained to the cases in which the administration of barium sulfate is not recommended or contraindicated F55 The intravascular administration of ioxitalamate is contraindicated as it may present significant side effects F54",
            "contraindications": {
                "disease": "Ioxitalamate is reported to induce acute kidney injury A33006 Preclinical studies showed that it does not present a teratogenic potential as well as a lack of effect on fertility F55 Ioxitalamate overdose may increase the risk of nephropathy and cardiovascular disorders F54",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Ioxitalamate presents a very large osmolality which is related to the presence of renal toxicity vasodilatation bradycardia and pulmonary hypertension This large osmolality allows ioxitalamate to move slowly in the bowel allowing for analysis for later follow excretion in the feces A33016",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}